NXL – nexalin technology, inc. (US:NASDAQ)

News

Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC™ Neurostimulation Console in Alzheimer’s Disease Program
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4
Nexalin Technology (NASDAQ:NXL) was downgraded by analysts at Wall Street
Nexalin Technology (NASDAQ:NXL) was downgraded by analysts at Wall Street
Nexalin Technology (NASDAQ:NXL) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com